CCNT1
Basic information
Region (hg38): 12:48688458-48716998
Previous symbols: [ "HIVE1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCNT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 40 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 2 | 0 |
Variants in CCNT1
This is a list of pathogenic ClinVar variants found in the CCNT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-48693089-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
12-48693178-G-C | not specified | Uncertain significance (Jan 07, 2025) | ||
12-48693220-T-G | not specified | Uncertain significance (Mar 02, 2023) | ||
12-48693316-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
12-48693325-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
12-48693367-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
12-48693375-C-A | not specified | Uncertain significance (Oct 12, 2022) | ||
12-48693470-C-G | not specified | Uncertain significance (Oct 04, 2024) | ||
12-48693523-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
12-48693559-C-T | not specified | Uncertain significance (Oct 20, 2021) | ||
12-48693571-C-T | not specified | Uncertain significance (Jan 22, 2025) | ||
12-48693587-C-T | not specified | Uncertain significance (Jan 16, 2025) | ||
12-48693618-T-A | not specified | Uncertain significance (Mar 15, 2024) | ||
12-48693691-T-A | not specified | Uncertain significance (Mar 28, 2024) | ||
12-48693719-T-C | not specified | Uncertain significance (May 23, 2024) | ||
12-48693733-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
12-48693734-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
12-48693766-C-A | not specified | Uncertain significance (Oct 05, 2023) | ||
12-48693767-G-A | not specified | Uncertain significance (Aug 04, 2021) | ||
12-48693784-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
12-48693805-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
12-48693826-C-T | not specified | Uncertain significance (Feb 18, 2025) | ||
12-48693858-C-T | Likely benign (Nov 01, 2023) | |||
12-48693869-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
12-48693889-T-A | not specified | Uncertain significance (Oct 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCNT1 | protein_coding | protein_coding | ENST00000261900 | 9 | 28435 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0511 | 0.949 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.08 | 333 | 393 | 0.847 | 0.0000205 | 4768 |
Missense in Polyphen | 73 | 108.01 | 0.67585 | 1305 | ||
Synonymous | -0.277 | 144 | 140 | 1.03 | 0.00000712 | 1431 |
Loss of Function | 3.62 | 8 | 29.0 | 0.276 | 0.00000140 | 360 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000141 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II). {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human);Initiation of transcription and translation elongation at the HIV-1 LTR;Disease;Signal Transduction;Gene expression (Transcription);Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;HIV elongation arrest and recovery;Formation of HIV elongation complex in the absence of HIV Tat;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Tat-mediated HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;Interactions of Tat with host cellular proteins;Host Interactions of HIV factors;HIV Infection;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Transcription Elongation;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;TP53 Regulates Transcription of DNA Repair Genes;Signaling by Nuclear Receptors;Transcriptional Regulation by TP53;Estrogen-dependent gene expression;TNFalpha;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;ESR-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.152
Intolerance Scores
- loftool
- 0.314
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.09
Haploinsufficiency Scores
- pHI
- 0.603
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccnt1
- Phenotype
Gene ontology
- Biological process
- regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;protein phosphorylation;cell cycle;viral process;positive regulation of DNA-templated transcription, elongation;snRNA transcription by RNA polymerase II;positive regulation by host of viral transcription;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of transcription by RNA polymerase II;positive regulation of viral transcription;cell division;negative regulation of mRNA polyadenylation
- Cellular component
- nucleus;nucleoplasm;nucleolus;cyclin/CDK positive transcription elongation factor complex
- Molecular function
- DNA binding;chromatin binding;protein serine/threonine kinase activity;protein binding;transcription factor binding;cyclin-dependent protein serine/threonine kinase regulator activity;protein kinase binding;transcription regulatory region DNA binding;cyclin-dependent protein serine/threonine kinase activator activity;RNA polymerase binding;7SK snRNA binding